Curcumin amends Ca2+ dysregulation in microglia by suppressing the activation of P2X7 receptor
- 105 Downloads
Curcumin (Cur) is widely used as an anti-inflammation agent and has anti-depression potential. Neuroinflammation mediated by Ca2+ channel activation is closely associated with the progression of post-stroke depression (PSD). In the current study, the role of P2X7 receptor (P2X7R) in the anti-PSD function of Cur was explored. Rats were subjected to middle cerebral artery occlusion (MCAO) surgery and chronic mild stress administration to induce PSD symptoms and then treated with Cur. The behaviors of rats were assessed with sucrose preference and forced swim tests. The accumulation of Ca2+ and the systemic inflammatory response in rats were detected. To determine the role of P2X7R in the anti-PSD function of curcumin, the PSD mice were further administrated with P2X7R agonist and antagonist. The administration of Cur attenuated behavior disorders associated with PSD. Moreover, the Ca2+ accumulation and the inflammatory response associated with PSD were also blocked by Cur. Cur also inhibited the activation of Ca2+ channel. The induced activity of P2X7R blocked the function of Cur by maintaining the symptoms of PSD in Cur-treated rats. Collectively, the anti-PSD function of Cur was dependent on the inhibition of P2X7R, which then deactivated Ca2+ channel-mediated inflammatory response associated with PSD progression.
KeywordsCa2+ channel Curcumin Neuroinflammation Post-stroke depression P2X7 receptor
This study was supported by the grants from the Science and Technology Research Project of Henan Province (172102310585).
Compliance with ethical standards
Conflict of interest
The authors disclose no conflict of interest.
- 1.Hackett ML, Yapa C, Parag V, Anderson CS (2005) Frequency of depression after stroke: a systematic review of observational studies. Stroke 36(6):1330–1340. https://doi.org/10.1161/01.STR.0000165928.19135.35 CrossRefPubMedGoogle Scholar
- 4.Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, Deruyter F, Eng JJ, Fisher B, Harvey RL, Lang CE, MacKay-Lyons M, Ottenbacher KJ, Pugh S, Reeves MJ, Richards LG, Stiers W, Zorowitz RD (2016) Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 47(6):e98–e169. https://doi.org/10.1161/STR.0000000000000098 CrossRefPubMedGoogle Scholar
- 13.Huang BR, Chang PC, Yeh WL, Lee CH, Tsai CF, Lin C, Lin HY, Liu YS, Wu CY, Ko PY, Huang SS, Hsu HC, Lu DY (2014) Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection. PLoS ONE 9(3):e91167. https://doi.org/10.1371/journal.pone.0091167 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Srimal RC, Dhawan BN (1973) Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25(6):447–452. https://doi.org/10.1111/j.2042-7158.1973.tb09131.x CrossRefPubMedGoogle Scholar
- 19.Zhang WY, Guo YJ, Han WX, Yang MQ, Wen LP, Wang KY, Jiang P (2019) Curcumin relieves depressive-like behaviors via inhibition of the NLRP3 inflammasome and kynurenine pathway in rats suffering from chronic unpredictable mild stress. Int Immunopharmacol 67:138–144. https://doi.org/10.1016/j.intimp.2018.12.012 CrossRefPubMedGoogle Scholar